Your session is about to expire
← Back to Search
Integrated vs. Coordinated Pain Management for Back Pain (AIM-BACK Trial)
AIM-BACK Trial Summary
This trial is testing whether an Integrated Care Pathway or a Coordinated Care Pathway is more effective in reducing pain and improving function for people with low back pain.
AIM-BACK Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowAIM-BACK Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.AIM-BACK Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- My healthcare team is ready to provide the required treatment.My healthcare team is available to provide the required treatment.My doctor thinks my lower back pain can be managed without surgery.You are getting treatment for lower back pain at a VA primary care clinic.I am currently receiving or have been referred for end-of-life care.My clinic sees a variety of back pain patients monthly.I am 18 years old or older.My clinic sees a variety of back pain patients each month.My doctor has referred me to a specific cancer care plan.Different staff and locations are needed for enrolled clinics than for other clinics.
- Group 1: Coordinated Care Management Pathway
- Group 2: Integrated Care Pathway
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What are the overarching goals of this clinical endeavor?
"This clinical trial, which will be assessed at two intervals (baseline and three months post baseline), aims to measure Change in Physical Function Measure. Secondary objectives involve evaluating the Change in Opioid Use--Morphine Dose with morphine equivalents for opioid dose at both baseline and twelve months as a continuous variable, gauging the Change in Patient reported Outcomes--PROMIS Sleep Disturbance with PROMIS Short form scores taken by interviewers over five different time points on a scale of 1-5 where one indicates an improved outcome, and assessing the Change in Patient Reported Outcomes--PROMIS Pain Interference via PR"
Is enrollment still open for the current clinical trial?
"Affirmative. According to the clinicaltrials.gov portal, this medical examination is actively seeking participants. It was first advertised on 8th March 2021 and subsequently updated 21st February 2022 with a target of 1,680 patients from one location."
How many participants are being evaluated in this clinical experiment?
"Affirmative, the clinicaltrials.gov findings show this trial is open for enrollment and was initially posted on 8th of March 2021. The last update occurred on 21st February 2022 and 1680 patients are needed in one location."
Who else is applying?
What state do they live in?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Share this study with friends
Copy Link
Messenger